
Michael Grundel Ison MD MS (He/Him)
Chief, Respiratory Diseases Branch, DMID/NIAID/NIH
Join to view full profile
3300 Gallows RdFalls Church, VA 22042
Phone+1 703-776-7075
Fax+1 703-776-2797
Dr. Ison is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Michael Ison is an Infectious Disease specialist. He completed his medical degree at the University of South Florida College of Medicine in 1997, followed by a residency in Internal Medicine at Oregon Health & Science University and a fellowship in Infectious Disease at the University of Virginia Medical Center. He further specialized in Transplant Infectious Diseases at Massachusetts General Hospital. His expertise includes general infectious diseases, transplantation, and wound management. He has contributed to significant publications in esteemed journals such as The Journal of Infectious Diseases and The Lancet and is editor-in-chief, Transplant Infectious Disease. Dr. Ison has been involved in various clinical trials focusing on infectious diseases in transplant and immunocompromised patients and has received multiple CMS Meaningful Use Stage Certifications.
Education & Training
Massachussetts General Hospital/HMSTransplant Infectious Diseases, Transplant Infectious Diseases, 2004 - 2005
University of VirginiaMS, Health Evaluation Sciences, 2001 - 2004
University of Virginia Medical CenterFellowship, Infectious Disease, 2004
Oregon Health & Science University (OHSU Health)Residency, Internal Medicine, 1997 - 2000
University of South Florida College of MedicineClass of 1997
Certifications & Licensure
VA State Medical License 2001 - 2028
MD State Medical License 2023 - 2026
IL State Medical License 2005 - 2023
OR State Medical License 1999 - 2000
American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2016
- CMS Meaningful Use Stage 1 Certification PowerChart, Cerner Corporation, 2013-2016
- CMS Meaningful Use Stage 1 Certification Northwestern Meaningful Use Data Warehouse Application for Eligible Providers, Northwestern University, 2013-2016
Clinical Trials
- Safety and Efficacy of Investigational Anti-Influenza Immune Plasma in Treating Influenza
- Pharmacokinetic Assessment of Peramivir in Hospitalized Adults Undergoing Continuous Renal Replacement Therapy
- Comparing the Efficacy, Safety, and Tolerability of Combination Antivirals (Amantadine, Ribavirin, Oseltamivir) Versus Oseltamivir for the Treatment of Influenza in Adults at Risk for Complications
Publications & Presentations
PubMed
- 1 citationsA phase 2 multicenter, prospective, randomized, double-blind study to assess the clinical and antiviral efficacy and safety of nitazoxanide for the treatment of norovi...Catherine-Audrey Boutin, Michelle Callegari, Diana Florescu, Minh-Hong Nguyen, Daniel Kaul
American Journal of Transplantation. 2026-09-01 - 3 citationsInnovation in active and passive immunisation of people who are immunocompromised: a call to action.Joshua A Hill, Jim Boonyaratanakornkit, Malgorzata Mikulska, Benjamin W Teh, William O Hahn
The Lancet. Infectious Diseases. 2026-01-01 - 3 citationsInfluenza Antivirals for Prevention and Treatment in Immunocompromised People.Madeleine R Heldman, Michael J Boeckh, Michael G Ison
The Journal of Infectious Diseases. 2025-10-17
Journal Articles
- Emergency Use Authorization of RemdesivirMichael G Ison, Cameron Wolfe, Helen W Boucher, JAMA
- Early Oseltamivir After Hospital Admission Is Associated with Shortened Hospitalization: A Five-Year Analysis of Oseltamivir Timing and Clinical OutcomesMichael G Ison, Rachel Kohn, Clinical Infectious Diseases
- Parainfluenza Virus in Hospitalized Adults: A 7-Year Retrospective StudyMichael G Ison, Elliott Russell, Clinical Infectious Diseases
Other
- Parainfluenza viruses in adultsIson MG
http://www.uptodate.com/contents/parainfluenza-viruses-in-adults
UpToDate, Wolters Kluwer Health - 2012-04-12
Authored Content
- Emergency Use Authorization of RemdesivirMay 2020
Press Mentions
As Bird Flu Concerns Grow, Scientists Race to Develop New VaccinesJanuary 17th, 2025
As Pace and Severity of Human H5N1 Cases Accelerate, NIH Leaders Call for More Action on Bird FluDecember 31st, 2024
New Reports Sharpen Clinical Picture of Recent Human H5N1 Illnesses in US and CanadaDecember 31st, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









